TB-500
A synthetic version of, or fragment from, thymosin beta-4, a natural protein involved in cell movement and wound repair.
- Evidence
- Primarily preclinical research
- Half-life
- Not known
- Sources
- 3 cited
Is TB-500 FDA-approved?
Not approved by the FDA. Products sold online as "research chemicals" aren't checked for purity, sterility or dose.
Is TB-500 banned in sport?
Banned in sport by the World Anti-Doping Agency (WADA).
Overview
Thymosin beta-4 is a 43-amino-acid protein found in almost every cell. It helps cells move into wounds. The full-length protein has been tested in small human trials for dry eye and slow-healing skin wounds, with modest results. "TB-500" sold online may be the full protein or a short fragment, and neither has proven benefits for sports injuries.
How it works
It binds actin, part of the cell's internal skeleton, which helps cells migrate. It also seems to calm inflammation and support new blood vessel growth.
How long does TB-500 stay in the body?
Not established for injected TB-500.
What it's studied for
- Wound and corneal healing
- Dry eye
- Heart repair after injury (animal studies)
Related: BPC-157, GHK-Cu, ARA-290 (Cibinetide), Semax. Compare: BPC-157 vs TB-500.
Sources
The studies and prescribing labels this page is written from.
- Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea, 2015 PubMed
- Thymosin β4 Promotes Dermal Healing. Vitam Horm, 2016 PubMed
- Thymosin beta 4 and the eye: the journey from bench to bedside. Expert Opin Biol Ther, 2018 PubMed